PMC:7200337 / 98633-98839 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1024","span":{"begin":36,"end":37},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T1025","span":{"begin":61,"end":66},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T1026","span":{"begin":116,"end":117},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"In one study, the authors developed a protocol to synthetize human nanobodies, smaller antibodies that only contain a variable heavy (VH) chain as first described in camelids (Wu et al., 2020c) (Figure 6D)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T320","span":{"begin":134,"end":136},"obj":"Chemical"}],"attributes":[{"id":"A320","pred":"chebi_id","subj":"T320","obj":"http://purl.obolibrary.org/obo/CHEBI_73700"}],"text":"In one study, the authors developed a protocol to synthetize human nanobodies, smaller antibodies that only contain a variable heavy (VH) chain as first described in camelids (Wu et al., 2020c) (Figure 6D)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3283","span":{"begin":47,"end":49},"obj":"Gene"},{"id":"3286","span":{"begin":61,"end":66},"obj":"Species"}],"attributes":[{"id":"A3283","pred":"tao:has_database_id","subj":"3283","obj":"Gene:6999"},{"id":"A3286","pred":"tao:has_database_id","subj":"3286","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In one study, the authors developed a protocol to synthetize human nanobodies, smaller antibodies that only contain a variable heavy (VH) chain as first described in camelids (Wu et al., 2020c) (Figure 6D)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T579","span":{"begin":0,"end":206},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In one study, the authors developed a protocol to synthetize human nanobodies, smaller antibodies that only contain a variable heavy (VH) chain as first described in camelids (Wu et al., 2020c) (Figure 6D)."}